CW July 2004
Volume 13Issue Number 7 July 2004 ISSN 10593802 One, Two Punch to Kidney Cancer Through Targeted TherapiesA highly active single agent that targets several receptors and a two-drug combination of targeted therapies shows great promise in difficult-to-treat metastatic renal cell carcinoma (RCC), according to reports at the American Society of Clinical Oncology annual meeting.
Go to Previous Page Go to Next Page Source & Additional Reading American Society of Clinical Oncology Annual Meeting. Purchase Downloadable Full-text PDF of Article: $10.00 Subscription is more cost effective than purchasing PDFs on-the-fly. Click here for details. Download Complete Issue CW July 2004Purchase Downloadable Full-text PDF of Complete Issue: $20.00 |
|
Member Login | Home | Offices | Subscribe | Glossary | Cancer Technologies | Contact Us
Adenine Press, 2066 Central Avenue, Schenectady, NY 12304 USA |
Re-initialize IP-based Login |
